Hematology

The Importance Of Being There For Your Patients

Halfway into my four-week hematology consults elective at the county hospital during my fourth year of medical school, I was surprised that one of my patients was a 25-year-old woman from Romania — exactly my age. This was highly unusual, as most...

Read More →

Why Arqule’s Early-stage Hematology Study Could Be Transformational

ArQule shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed or refractory hematologic malignancies at the 2019 European...
Related topics: Medical Research

Read More →

Potential Targeted Treatment For Acute Myeloid Leukemia Identified

Scientists from Sanford Burnham Prebys have shown that a protein called BMI1 is a promising drug target for an AML subtype in which two normally separate genes, CALM and AF10, fuse together. The findings, published in Experimental Hematology,...
Related topics: Leukemia, Proteins, Genetics

Read More →

Is Tg Therapeutics A Buy?

TG Therapeutics (NASDAQ: TGTX), a clinical-stage hematology and autoimmune disease specialist, has been crushing the broader stock market this year. The biotech's shares surged higher in response to the news that the company's relapsed and...
Related topics: Nasdaq

Read More →

Gene-based Factor Viia Prevents Bleeding Episodes In Animals With Hemophilia

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in animals may set the stage for a new therapy for a...
Related topics: Genetics, Medical Research

Read More →

January 2019 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

Ash Develops Practice Guidelines For Venous Thromboembolism

THURSDAY, Dec. 27, 2018 -- The American Society of Hematology (ASH) has developed new guidelines for the treatment of venous thromboembolism (VTE); the clinical practice guidelines were recently published in Blood Advances. The guidelines address...

Read More →

Health Tip: Understanding Blood Clots

-- Blood clotting is the body's way of preventing excessive bleeding when a blood vessel is injured. Typically, the body will dissolve the clot after the injury has healed, the American Society of Hematology says. But occasionally, a clot forms...

Read More →

American Society Of Hematology, Dec. 1-4

The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec. 1 to 4 in San Diego and attracted approximately 22,000 participants from around the world, including...

Read More →

Gilead (gild) Announces Data On Car T Therapy Candidate

Kite, a Gilead Sciences GILD company, announced updated results from a phase I/II study, ZUMA-3, on experimental candidate KTE-X19 at the Annual Meeting of the American Society of Hematology (ASH).KTE-C19 is a CD19 chimeric antigen receptor T (CAR...
Related topics: Medical Research

Read More →

November 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

What's Hot At This Year's Ash Meeting?

Big results from big trials in leukemia and lymphoma will be presented and are 'almost certainly going to be practice changing,' says American Society of Hematology (ASH) Secretary Robert Brodsky, MD. Medscape Medical News
Related topics: Leukemia, Lymphoma

Read More →

Here's Why Sangamo Therapeutics Lost 12% Today

After reporting preliminary results for its hemophilia A therapy that excited investors in August, Sangamo Therapeutics (NASDAQ: SGMO) has backed away from plans to present the data at the fast-approaching American Society of Hematology (ASH)...
Related topics: Nasdaq

Read More →

October 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

Fostamatinib Seems Effective For Immune Thrombocytopenia

WEDNESDAY, Sept. 5, 2018 -- Fostamatinib produces clinically meaningful responses in adults with immune thrombocytopenia (ITP), according a study published in the July issue of the American Journal of Hematology. James Bussel, M.D., from Weill...
Related topics: Medical Research

Read More →

Mount Sinai Receives $4 Million Grant To Study Use Of Inhaled Corticosteroids For Sickle Cell...

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell...
Related topics: Medical Research

Read More →

Mount Sinai Receives $4 Million Grant To Study Use Of Inhaled Corticosteroids For Sickle Cell...

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell...
Related topics: Medical Research

Read More →

July 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for July 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

Pixcell Medical Presents The Hemoscreen: Blood Testing At The Point Of Care

PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The...

Read More →

National Comprehensive Cancer Network Begins Work On Guidelines To Improve Cancer Care In The...

National Comprehensive Cancer Network collaborates with the Caribbean Association for Oncology & Hematology to create NCCN Harmonized Guidelines for the Caribbean
Related topics: Cancer, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.